At G.S.K, we believe that prevention is the best medicine. Prevention is pioneering new medicines to reduce HIV transmission, applying decades of experience and asthma control to limit long-term lung damage or stopping chronic conditions from progressing to most serious complications

because preventing disease is the best possible outcome for all of us and is why GSK

unites science, technology and talent to get ahead of

disease together. Visit gsk.com to learn more.

Behind the Knife, the Surgery Podcast, where we take a behind the scenes intimate look at surgery

from leaders in the Knife. This week on the

podcast we have our second grand round series. Dr. Jennifer Laffa

meana from the University of Massachusetts has graciously sent us a great rundown on melanoma as well as the

treatment and management. Additionally if anybody has any ideas to include

topics or guests for our Grand Riles series, send them our way.

Enjoy.

Good afternoon.

My name is Jennifer Laffa Mina and I am a surgical oncologist from the University of Massachusetts.

I want to thank you for allowing me to talk with you today

about the surgical management of melanoma. Today we're really going to focus our

discussion on the surgical management of the primary lesion, the regional lymphatics, and to some extent

the management of metastatic disease.

First and foremost, prior to the 1980s, a 5 centimeter margin was the standard therapy for the

resection of primary melanomas.

As you might imagine, this nearly universally required skin grafting.

Over the number of years, the number of trials have been conducted as to establish the optimal margins for

resection. What is important to note is that no trial has ever demonstrated a

...